{"id":"W2336729059","doi":"10.1016/s1556-0864(16)30288-x","title":"178P: Continuation of ceritinib beyond disease progression is associated with prolonged post-progression survival (PPS) in ALK+ NSCLC","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ignyta; EMD Serono; Pfizer; Daiichi-Sankyo; Novartis Pharma; Ariad Pharmaceuticals; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"Ceritinib; Medicine; Internal medicine; Crizotinib; Oncology; Hazard ratio; Confidence interval; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000694151,0.0003124895,0.0005617563,0.0001864313,0.000396696,0.0007297067,0.0005528961,0.001120874,0.007270308],"category_scores_gemma":[0.002460801,0.0001669851,0.001068426,0.0003993443,0.0003365823,0.0008157106,0.0004557688,0.001685176,0.0014203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003784023,"about_ca_system_score_gemma":0.0004518918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007335037,"about_ca_topic_score_gemma":0.001095756,"domain_scores_codex":[0.9994355,0.0001060755,0.00006481951,0.0001372703,0.0001269845,0.0001292712],"domain_scores_gemma":[0.9974588,0.0007045193,0.00106537,0.00016606,0.0001696519,0.0004356257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05617954,0.0007291159,0.7208191,0.0007644283,0.002125147,0.005068153,0.0002143431,0.001969302,0.04317497,0.001102768,0.01124323,0.15661],"study_design_scores_gemma":[0.0007581795,0.004983825,0.9628865,0.0001002665,0.001424003,0.009006835,0.0001835827,0.001844249,0.004296591,0.001759562,0.01269637,0.00006011893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905696,0.002133277,0.0004997209,0.0008010729,0.0001459066,0.00002624672,0.001469185,0.00006006457,0.004294833],"genre_scores_gemma":[0.9970769,0.000183871,0.0001509592,0.0002414844,0.0001579746,0.00001675873,0.0009939868,0.000021833,0.00115624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007270308,"threshold_uncertainty_score":0.02432162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01713439872165762,"score_gpt":0.4336444981035597,"score_spread":0.416510099381902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}